Arcturus Therapeutics Holdings Inc. (ARCT) KPIs and segments
Close on Nov 13, 2026Market cap $237.62MP/E –Yield –
KPIs & segments
Operating metrics and segments that drive Arcturus Therapeutics's business
Arcturus Therapeutics's revenue by segment, product and region, plus the counts and sizes it tags in its 10-K and 10-Q filings (XBRL). Each figure links to the filing it came from. A fuller KPI sheet built from earnings releases and presentations is on the way. See the segment tables for a trailing-twelve-month view, or how companies compare on operating metrics.
The chart is empty. Tick the box next to any metric in the table below to plot it — tick several to compare them on one chart.
| Add to chart | Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Grant Revenue($M) | 2.08 | 1.45 | 4.12 | 3.00 | 3.79 | 3.91 | 1.77 | 2.86 | 3.88 | 5.41 | 5.78 | 1.76 | |
Collaboration Revenue($M) | 0.88 | 0.61 | 3.08 | 14.2 | 24.5 | 25.5 | 21 | 38.8 | 46.0 | 32.6 | 25.1 | 43.4 | |
1 metric has no data in the last 12 quarters — .
Italic numbers are calculated by StockData from reported figures (hover for the formula). Numbers with a dotted underline are read from the text of earnings releases and presentations; hover to see the exact sentence. Tick a row to add it to the chart above (up to 8 lines).
Methodology and excluded metrics
- Core rows come from the segment and revenue-disaggregation notes of 10-K and 10-Q filings (XBRL), linked to each filing. Fourth-quarter figures are the fiscal year less the first nine months (shown in italic).
Data updated 2026-08-06.
See a number that looks wrong?